Milestone Scientific (NYSE:MLSS) Now Covered by Analysts at StockNews.com

StockNews.com started coverage on shares of Milestone Scientific (NYSE:MLSS) in a research report released on Wednesday. The firm issued a hold rating on the stock.

Separately, Benchmark restated a “speculative buy” rating and issued a $1.25 price objective on shares of Milestone Scientific in a report on Wednesday, November 20th.

Milestone Scientific Price Performance

Shares of NYSE MLSS opened at $0.81 on Wednesday. The company’s 50 day simple moving average is $0.82 and its 200 day simple moving average is $0.85. Milestone Scientific has a fifty-two week low of $0.52 and a fifty-two week high of $1.10. The firm has a market capitalization of $62.79 million, a P/E ratio of -11.52 and a beta of 1.10.

Insider Buying and Selling at Milestone Scientific

In other Milestone Scientific news, Director Leonard Osser sold 107,984 shares of the company’s stock in a transaction that occurred on Tuesday, October 22nd. The shares were sold at an average price of $0.93, for a total value of $100,425.12. Following the completion of the sale, the director now owns 4,606,882 shares of the company’s stock, valued at approximately $4,284,400.26. This represents a 2.29 % decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through the SEC website. Over the last 90 days, insiders sold 109,193 shares of company stock valued at $101,634. Corporate insiders own 24.75% of the company’s stock.

Institutional Investors Weigh In On Milestone Scientific

Several large investors have recently made changes to their positions in the stock. Geode Capital Management LLC increased its position in shares of Milestone Scientific by 6.4% during the third quarter. Geode Capital Management LLC now owns 527,005 shares of the company’s stock worth $480,000 after acquiring an additional 31,572 shares in the last quarter. World Investment Advisors LLC bought a new stake in shares of Milestone Scientific during the third quarter worth $91,000. Finally, Y Intercept Hong Kong Ltd bought a new stake in shares of Milestone Scientific during the third quarter worth $48,000. Institutional investors own 5.79% of the company’s stock.

Milestone Scientific Company Profile

Milestone Scientific Inc, a biomedical technology research and development company, patents, designs, develops, and commercializes diagnostic and therapeutic injection technologies, and devices for medical, dental, and cosmetic use in the United States, China, and internationally. The company operates through Dental and Medical segments.